- No clear beneficiaries surfaced yet.
Protect Infant Formula from Contamination Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
<p><strong>Protect Infant Formula from Contamination Act</strong></p><p>This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. </p><p>Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. </p><p>Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. </p><p>Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. </p><p>Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues. </p>
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The next hurdle is converting committee movement into a floor coalition.
<p><strong>Protect Infant Formula from Contamination Act</strong></p><p>This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. </p><p>Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. </p><p>Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product.
The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. </p><p>Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. </p><p>Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues. </p>
This bill has moved beyond introduction, but committee and floor dynamics still determine whether it can build durable support.
How solid the drafting looks.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- No clear downsides surfaced yet.
Why the argument around this bill splits.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
This bill has moved beyond introduction, but committee and floor dynamics still determine whether it can build durable support.
- The next hurdle is converting committee movement into a floor coalition.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
This bill has moved beyond introduction, but committee and floor dynamics still determine whether it can build durable support.
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Protect Infant Formula from Contamination Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.